Actavis Puts Greater Emphasis On Branded Rx By Taking Allergan Name
This article was originally published in The Pink Sheet Daily
Executive Summary
The growing spec pharma has seen a 300% increase in its branded portfolio revenues since the acquisition of Forest and Warner Chilcott and is honoring the new direction by taking on the name of its most recent acquisition.